291 related articles for article (PubMed ID: 34406864)
41. The clinically used serine protease inhibitor nafamostat reduces influenza virus replication and cytokine production in human airway epithelial cells and viral replication in mice.
Yamaya M; Shimotai Y; Ohkawara A; Bazarragchaa E; Okamatsu M; Sakoda Y; Kida H; Nishimura H
J Med Virol; 2021 Jun; 93(6):3484-3495. PubMed ID: 33247612
[TBL] [Abstract][Full Text] [Related]
42. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus.
Rosenthal PB; Zhang X; Formanowski F; Fitz W; Wong CH; Meier-Ewert H; Skehel JJ; Wiley DC
Nature; 1998 Nov; 396(6706):92-6. PubMed ID: 9817207
[TBL] [Abstract][Full Text] [Related]
43. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis.
Lambertz RLO; Gerhauser I; Nehlmeier I; Leist SR; Kollmus H; Pöhlmann S; Schughart K
J Gen Virol; 2019 Jul; 100(7):1073-1078. PubMed ID: 31099738
[TBL] [Abstract][Full Text] [Related]
44. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.
Glowacka I; Bertram S; Müller MA; Allen P; Soilleux E; Pfefferle S; Steffen I; Tsegaye TS; He Y; Gnirss K; Niemeyer D; Schneider H; Drosten C; Pöhlmann S
J Virol; 2011 May; 85(9):4122-34. PubMed ID: 21325420
[TBL] [Abstract][Full Text] [Related]
45. TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus.
Sakai K; Ami Y; Nakajima N; Nakajima K; Kitazawa M; Anraku M; Takayama I; Sangsriratanakul N; Komura M; Sato Y; Asanuma H; Takashita E; Komase K; Takehara K; Tashiro M; Hasegawa H; Odagiri T; Takeda M
Sci Rep; 2016 Jul; 6():29430. PubMed ID: 27389476
[TBL] [Abstract][Full Text] [Related]
46. Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations.
Ramakrishnan J; Kandasamy S; Iruthayaraj A; Magudeeswaran S; Chinnasamy K; Poomani K
Appl Biochem Biotechnol; 2021 Jun; 193(6):1909-1923. PubMed ID: 33512650
[TBL] [Abstract][Full Text] [Related]
47. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice.
Hatesuer B; Bertram S; Mehnert N; Bahgat MM; Nelson PS; Pöhlmann S; Schughart K
PLoS Pathog; 2013; 9(12):e1003774. PubMed ID: 24348248
[TBL] [Abstract][Full Text] [Related]
48. Establishment of a genetically engineered chicken DF-1 cell line for efficient amplification of influenza viruses in the absence of trypsin.
Chungu K; Park YH; Woo SJ; Lee SB; Rengaraj D; Lee HJ; Han JY
BMC Biotechnol; 2021 Jan; 21(1):2. PubMed ID: 33413322
[TBL] [Abstract][Full Text] [Related]
49. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.
Magnen M; Gueugnon F; Guillon A; Baranek T; Thibault VC; Petit-Courty A; de Veer SJ; Harris J; Humbles AA; Si-Tahar M; Courty Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28615200
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
[TBL] [Abstract][Full Text] [Related]
51. Genetic Evolution and Molecular Selection of the HE Gene of Influenza C Virus.
Zhang W; Zhang L; He W; Zhang X; Wen B; Wang C; Xu Q; Li G; Zhou J; Veit M; Su S
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791465
[TBL] [Abstract][Full Text] [Related]
52. Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium.
Singanayagam A; Zambon M; Barclay WS
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189708
[TBL] [Abstract][Full Text] [Related]
53. In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity.
Fujimoto KJ; Hobbs DCF; Umeda M; Nagata A; Yamaguchi R; Sato Y; Sato A; Ohmatsu K; Ooi T; Yanai T; Kimura H; Murata T
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215982
[TBL] [Abstract][Full Text] [Related]
54. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.
Bertram S; Heurich A; Lavender H; Gierer S; Danisch S; Perin P; Lucas JM; Nelson PS; Pöhlmann S; Soilleux EJ
PLoS One; 2012; 7(4):e35876. PubMed ID: 22558251
[TBL] [Abstract][Full Text] [Related]
55. Proteolytic activation of the 1918 influenza virus hemagglutinin.
Chaipan C; Kobasa D; Bertram S; Glowacka I; Steffen I; Tsegaye TS; Takeda M; Bugge TH; Kim S; Park Y; Marzi A; Pöhlmann S
J Virol; 2009 Apr; 83(7):3200-11. PubMed ID: 19158246
[TBL] [Abstract][Full Text] [Related]
56. Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin.
Zmora P; Molau-Blazejewska P; Bertram S; Walendy-Gnirß K; Nehlmeier I; Hartleib A; Moldenhauer AS; Konzok S; Dehmel S; Sewald K; Brinkmann C; Curths C; Knauf S; Gruber J; Mätz-Rensing K; Dahlmann F; Braun A; Pöhlmann S
PLoS One; 2017; 12(5):e0176597. PubMed ID: 28493964
[TBL] [Abstract][Full Text] [Related]
57. The role of stearate attachment to the hemagglutinin-esterase-fusion glycoprotein HEF of influenza C virus.
Wang M; Ludwig K; Böttcher C; Veit M
Cell Microbiol; 2016 May; 18(5):692-704. PubMed ID: 26518983
[TBL] [Abstract][Full Text] [Related]
58. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities.
Hamilton BS; Gludish DW; Whittaker GR
J Virol; 2012 Oct; 86(19):10579-86. PubMed ID: 22811538
[TBL] [Abstract][Full Text] [Related]
59. Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.
Reinke LM; Spiegel M; Plegge T; Hartleib A; Nehlmeier I; Gierer S; Hoffmann M; Hofmann-Winkler H; Winkler M; Pöhlmann S
PLoS One; 2017; 12(6):e0179177. PubMed ID: 28636671
[TBL] [Abstract][Full Text] [Related]
60. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
Kido H; Takahashi E; Kimoto T
Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
